Borosil-brand maker of lab glassware, equipment, process reactors and pharma glass ampoules/vials in India.
Price
Market Cap
Sector
Industrials
Rank
| Line item | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|
| LiabilitiesEquity Capital | 9 | 9 | 9 | 9 |
| Reserves | 367 | 395 | 396 | 432 |
| Borrowings | 18 | 14 | 9 | 9 |
| Other Liabilities | 95 | 86 | 89 | 99 |
| Total Liabilities | 488 | 504 | 502 | 549 |
| AssetsFixed Assets | 192 | 187 | 185 | 189 |
| CWIP | 1 | 1 | 2 | 9 |
| Investments | 0 | 105 | 108 | 122 |
| Other Assets | 295 | 210 | 207 | 229 |
| Total Assets | 488 | 504 | 502 | 549 |
| Line item | FY24 | FY25 | FY26 |
|---|---|---|---|
| ActivitiesCash from Operating | 30 | 120 | 43 |
| Cash from Investing | -2 | -115 | -37 |
| Cash from Financing | -16 | -3 | -6 |
| SummaryCapital Expenditure | — | — | — |
| Free Cash Flow | 17 | 106 | 16 |
| FCF Margin | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (58.2×) and current (41.3×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 23.4% growth and a 41× exit, ₹161 only delivers your return if you pay ₹209. The price is currently baking in 18% growth.
EPS grows 23.4%/yr for 5 years, then fades to 6% over 2, exits at 41×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 23.4% | 4.80 |
| FY28 | 23.4% | 5.92 |
| FY29 | 23.4% | 7.31 |
| FY30 | 23.4% | 9.02 |
| FY31 | 23.4% | 11.13 |
| FY32 | 14.7% ·fade | 12.77 |
| FY33 | 6.0% ·fade | 13.53 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.